Solid science but limited stability - Recensione dipendente - Scientist presso ImmPACT Bio

4,0
28 ago 2025
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Promising CAR-T product with strong phase I results; fast-pace and collaborative environment.

Svantaggi

Company was acquired due to low valuation, followed by site closure and layoffs

Esplora altre recensioni su ImmPACT Bio

4,0
2 giu 2025
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Pay is great. Most teams are pretty flexible. WFH opportunities.

Svantaggi

Sold to Lyell and company went downhill.

2,0
19 set 2024
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Science is interesting, though in crowded market place, is it differentiated enough?

Svantaggi

Company culture , challenges in ability to execute, over-stretched key leaders who aren't available in any meaningful way for direct reports.

Vedi recensioni per: Utile|Valutazione|Data|Tutto